Literature DB >> 7396470

New schedule for tobramycin administration.

R D Lawson, G P Bodey, T Pan, T L Smith.   

Abstract

Ten patients received a loading dose of tobramycin of 60 mg/m2 intravenously over 0.5 h followed immediately by 60 mg/m2 over 2 h every 4 h. The highest mean serum concentration (at the end of the loading dose) was 6.0 +/- 0.3 microgram/ml (range, 3.2 to 10.9 microgram/ml). The mean serum concentration 2 h after the end of the initial 2-h infusion was 3.0 +/- 0.2 microgram/ml (range, 1.6 to 3.9 microgram/ml). This schedule of tobramycin was used to treat 117 patients with presumed or proven infection. There were no differences in the mean serum concentrations of tobramycin at comparable times on days 3 to 4 and 6 to 7. Only 60% of patients had serum levels between 3 micrograms/ml (trough) and 10 micrograms/ml (peak). This intermittent schedule of administration resulted in substantial fluctuations in serum concentrations of tobramycin and produced trough concentrations which were too low or peak concentrations which were too high in some patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7396470      PMCID: PMC283883          DOI: 10.1128/AAC.17.5.834

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Radioimmunoassay of iodinated tobramycin.

Authors:  A Broughton; J E Strong; L K Pickering; G P Bodney
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

2.  Causes of death in patients with malignant lymphoma.

Authors:  R Feld; G P Bodey; V Rodriguez; M Luna
Journal:  Am J Med Sci       Date:  1974-08       Impact factor: 2.378

3.  Proceedings: Causes of death in cancer patients.

Authors:  J Inagaki; V Rodriguez; G P Bodey
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

4.  Feasibility of administering aminoglycoside antibiotics by continuous intravenous infusion.

Authors:  G P Bodey; H Y Chang; V Rodriguez; D Stewart
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

5.  Amikacin therapy of infections in neutropenic patients.

Authors:  M Valdivieso; R Feld; V Rodriguez; G P Bodey
Journal:  Am J Med Sci       Date:  1975 Nov-Dec       Impact factor: 2.378

6.  Relation between dose and levels of gentamicin in blood.

Authors:  R E Winters; K D Litwack; W L Hewitt
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.